---
figid: PMC4895922__nihms775769f7
figlink: /pmc/articles/PMC4895922/figure/F7/
number: Figure 7
caption: Tamoxifen directly inhibits the mitochondrial electron transport chain at
  complex I. This results in a decrease in consumption of O2 by complex IV and an
  increase in the AMP:ATP ratio activating AMPK and promoting glycolysis and autophagy.
  AMPK signaling inhibits the mTOR pathway and translation resulting in cell death
  following tamoxifen treatment. Modulation of fatty acid metabolism may involve direct
  inhibitory action of tamoxifen on FASN activity.
pmcid: PMC4895922
papertitle: AMPK activation and metabolic reprogramming by tamoxifen through estrogen
  receptor-independent mechanisms suggests new uses for this therapeutic modality
  in cancer treatment.
reftext: Natalie A. Daurio, et al. Cancer Res. ;76(11):3295-3306.
pmc_ranked_result_index: '10839'
pathway_score: 0.9412969
filename: nihms775769f7.jpg
figtitle: AMPK activation and metabolic reprogramming by tamoxifen through estrogen
  receptor-independent mechanisms suggests new uses for this therapeutic modality
  in cancer treatment
year: ''
organisms: Homo sapiens
ndex: f837a191-df04-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4895922__nihms775769f7.html
  '@type': Dataset
  description: Tamoxifen directly inhibits the mitochondrial electron transport chain
    at complex I. This results in a decrease in consumption of O2 by complex IV and
    an increase in the AMP:ATP ratio activating AMPK and promoting glycolysis and
    autophagy. AMPK signaling inhibits the mTOR pathway and translation resulting
    in cell death following tamoxifen treatment. Modulation of fatty acid metabolism
    may involve direct inhibitory action of tamoxifen on FASN activity.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTOR
  - PRKAB2
  - PRKAG2
  - MFAP1
  - CHPT1
  - FASN
  - ACACA
  - PRKAB1
  - PRKAA1
  - PRKAA2
  - PRKAG3
  - PRKAG1
  - ACACB
  - Palmitate
genes:
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: AMP
  symbol: AMP
  source: hgnc_alias_symbol
  hgnc_symbol: MFAP1
  entrez: '4236'
- word: CPT1
  symbol: CPT1
  source: hgnc_alias_symbol
  hgnc_symbol: CHPT1
  entrez: '56994'
- word: FASN
  symbol: FASN
  source: hgnc_symbol
  hgnc_symbol: FASN
  entrez: '2194'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACA
  entrez: '31'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: ACC
  symbol: ACC
  source: bioentities_symbol
  hgnc_symbol: ACACB
  entrez: '32'
chemicals:
- word: Palmitate
  source: MESH
  identifier: D010168
diseases: []
---
